vs
CALIFORNIA WATER SERVICE GROUP（CWT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是CALIFORNIA WATER SERVICE GROUP的1.0倍（$219.9M vs $210.7M），CALIFORNIA WATER SERVICE GROUP净利率更高（5.4% vs -1.0%，领先6.5%），Orthofix Medical Inc.同比增速更快（2.0% vs -3.3%），过去两年CALIFORNIA WATER SERVICE GROUP的营收复合增速更高（16.6% vs 8.0%）
加利福尼亚水务集团是美国公共事业企业，主营饮用水及污水处理服务，是美国第三大上市投资者所有水务公司，通过加利福尼亚、夏威夷、新墨西哥、华盛顿等州的子公司，为约200万民众提供服务。集团成立于1997年，作为加州水务的控股主体，推动业务向美国其他各州拓展。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CWT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.0倍
$210.7M
营收增速更快
OFIX
高出5.3%
-3.3%
净利率更高
CWT
高出6.5%
-1.0%
两年增速更快
CWT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $210.7M | $219.9M |
| 净利润 | $11.5M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 12.2% | 0.2% |
| 净利率 | 5.4% | -1.0% |
| 营收同比 | -3.3% | 2.0% |
| 净利润同比 | -41.0% | 92.4% |
| 每股收益（稀释后） | $0.19 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CWTOFIX
| Q4 25 | $210.7M | $219.9M | ||
| Q3 25 | $314.1M | $205.6M | ||
| Q2 25 | $256.2M | $203.1M | ||
| Q1 25 | $182.7M | $193.6M | ||
| Q4 24 | $217.8M | $215.7M | ||
| Q3 24 | $306.2M | $196.6M | ||
| Q2 24 | $226.7M | $198.6M | ||
| Q1 24 | $154.9M | $188.6M |
净利润CWTOFIX
| Q4 25 | $11.5M | $-2.2M | ||
| Q3 25 | $61.2M | $-22.8M | ||
| Q2 25 | $42.2M | $-14.1M | ||
| Q1 25 | $13.3M | $-53.1M | ||
| Q4 24 | $19.5M | $-29.1M | ||
| Q3 24 | $60.7M | $-27.4M | ||
| Q2 24 | $40.6M | $-33.4M | ||
| Q1 24 | $69.9M | $-36.0M |
毛利率CWTOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率CWTOFIX
| Q4 25 | 12.2% | 0.2% | ||
| Q3 25 | 22.5% | -8.3% | ||
| Q2 25 | 20.2% | -7.9% | ||
| Q1 25 | 12.2% | -25.2% | ||
| Q4 24 | 14.8% | -5.3% | ||
| Q3 24 | 21.8% | -9.6% | ||
| Q2 24 | 21.2% | -12.5% | ||
| Q1 24 | 50.3% | -15.6% |
净利率CWTOFIX
| Q4 25 | 5.4% | -1.0% | ||
| Q3 25 | 19.5% | -11.1% | ||
| Q2 25 | 16.5% | -6.9% | ||
| Q1 25 | 7.3% | -27.4% | ||
| Q4 24 | 8.9% | -13.5% | ||
| Q3 24 | 19.8% | -13.9% | ||
| Q2 24 | 17.9% | -16.8% | ||
| Q1 24 | 45.1% | -19.1% |
每股收益（稀释后）CWTOFIX
| Q4 25 | $0.19 | $-0.05 | ||
| Q3 25 | $1.03 | $-0.57 | ||
| Q2 25 | $0.71 | $-0.36 | ||
| Q1 25 | $0.22 | $-1.35 | ||
| Q4 24 | $0.31 | $-0.76 | ||
| Q3 24 | $1.03 | $-0.71 | ||
| Q2 24 | $0.70 | $-0.88 | ||
| Q1 24 | $1.21 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.8M | $82.0M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $1.7B | $450.0M |
| 总资产 | $5.7B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.87× | — |
8季度趋势，按日历期对齐
现金及短期投资CWTOFIX
| Q4 25 | $51.8M | $82.0M | ||
| Q3 25 | $76.0M | $62.9M | ||
| Q2 25 | $50.5M | $65.6M | ||
| Q1 25 | $44.5M | $58.0M | ||
| Q4 24 | $50.1M | $83.2M | ||
| Q3 24 | $59.6M | $30.1M | ||
| Q2 24 | $37.3M | $26.4M | ||
| Q1 24 | $42.8M | $27.0M |
总债务CWTOFIX
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.1B | $157.2M | ||
| Q2 25 | $1.1B | $157.0M | ||
| Q1 25 | $1.1B | $156.9M | ||
| Q4 24 | $1.1B | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益CWTOFIX
| Q4 25 | $1.7B | $450.0M | ||
| Q3 25 | $1.7B | $442.5M | ||
| Q2 25 | $1.7B | $458.3M | ||
| Q1 25 | $1.6B | $458.3M | ||
| Q4 24 | $1.6B | $503.1M | ||
| Q3 24 | $1.6B | $525.9M | ||
| Q2 24 | $1.5B | $546.0M | ||
| Q1 24 | $1.5B | $570.3M |
总资产CWTOFIX
| Q4 25 | $5.7B | $850.6M | ||
| Q3 25 | $5.5B | $832.6M | ||
| Q2 25 | $5.4B | $837.2M | ||
| Q1 25 | $5.3B | $823.1M | ||
| Q4 24 | $5.2B | $893.3M | ||
| Q3 24 | $5.0B | $867.9M | ||
| Q2 24 | $4.9B | $882.0M | ||
| Q1 24 | $4.8B | $906.0M |
负债/权益比CWTOFIX
| Q4 25 | 0.87× | — | ||
| Q3 25 | 0.65× | 0.36× | ||
| Q2 25 | 0.67× | 0.34× | ||
| Q1 25 | 0.68× | 0.34× | ||
| Q4 24 | 0.67× | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $47.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | 4.17× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流CWTOFIX
| Q4 25 | $47.9M | $27.7M | ||
| Q3 25 | $167.3M | $12.4M | ||
| Q2 25 | $48.9M | $11.6M | ||
| Q1 25 | $38.4M | $-18.4M | ||
| Q4 24 | $68.1M | $23.7M | ||
| Q3 24 | $101.8M | $11.7M | ||
| Q2 24 | $94.4M | $9.0M | ||
| Q1 24 | $26.5M | $-18.6M |
自由现金流CWTOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率CWTOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度CWTOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率CWTOFIX
| Q4 25 | 4.17× | — | ||
| Q3 25 | 2.73× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 2.88× | — | ||
| Q4 24 | 3.50× | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | 2.33× | — | ||
| Q1 24 | 0.38× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CWT
| Residential | $133.2M | 63% |
| Business | $47.7M | 23% |
| Public Authorities | $13.4M | 6% |
| Industrial | $6.9M | 3% |
| Non Regulated Services | $4.8M | 2% |
| Other Non Regulated Service | $1.2M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
